Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramos, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramos, E. L.

Journal of the American Society of Nephrology, Vol 2, 109-121, Copyright © 1991 by American Society of Nephrology

REVIEWS

Recurrent diseases in the renal allograft

EL Ramos
Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville 32610-0224.

Although recurrent diseases in the renal transplant are becoming increasing recognized as graft survival continue to improve, they account for less than 2 to 4% of all allograft failures. The most frequent cause of recurrent disease is recurrent glomerulonephritis. Among the recurrent glomerulonephritides, type II membranoproliferative glomerulonephritis, immunoglobulin A nephropathy, and focal and segmental glomerulosclerosis have the highest rates of recurrence. The observation continues to be substantiated that recurrence rates are increased in recipients of living-related transplants, particularly in those whose original native kidney disease was focal and segmental glomerulosclerosis, immunoglobulin A nephropathy, membranous glomerulonephritis, Henoch-Schonlein purpura, or the hemolytic uremic syndrome. Additionally, although renal transplantation has been felt to be contraindicated in patients with Fabry's disease, more recent experience with improved patient survival and decreased morbidity would suggest that transplantation may be a viable alternative for this systemic illness.


This article has been cited by other articles:


Home page
 JAMAHome page
G. M. Chertow
A 43-Year-Old Woman With Chronic Renal Insufficiency
JAMA, March 10, 2004; 291(10): 1252 - 1259.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. RAI, C. NAST, and S. ADLER
Henoch-Schonlein Purpura Nephritis
J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2637 - 2644.
[Full Text]

Home page
 J. Cell Sci.Home page
P. Nelson, K Moissoglu, J Vargas, P. Klotman, and I. Gelman
Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells
J. Cell Sci., January 2, 1999; 112(3): 361 - 370.
[Abstract] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673